Loading company…
Triomics uses AI to structure patient records for oncology care and clinical research.
Triomics analyzes unstructured electronic health records to support oncology workflows, including clinical trial matching. Its platform serves cancer centers and oncology practices and integrates with electronic medical record systems. Founded in 2021, the company is based in New York, US. It raised USD 22 mn in Series B funding in May 2026, led by Battery Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in